Display options
Cite
van Kasteren PB, van der Veer B, Reusken CBEM, et al. Response to letter of concern by Oladimeji and Pickford of PrimerDesign. J Clin Virol. 2020;129:104526doi: 10.1016/j.jcv.2020.104526.
van Kasteren, P. B., van der Veer, B., Reusken, C. B. E. M., & Meijer, A. (2020). Response to letter of concern by Oladimeji and Pickford of PrimerDesign. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 129104526. https://doi.org/10.1016/j.jcv.2020.104526
van Kasteren, Puck B, et al. "Response to letter of concern by Oladimeji and Pickford of PrimerDesign." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 129 (2020): 104526. doi: https://doi.org/10.1016/j.jcv.2020.104526
van Kasteren PB, van der Veer B, Reusken CBEM, Meijer A. Response to letter of concern by Oladimeji and Pickford of PrimerDesign. J Clin Virol. 2020 Aug;129:104526. doi: 10.1016/j.jcv.2020.104526. Epub 2020 Jun 29. PMID: 32683281; PMCID: PMC7323679.
Copy Download .nbib Format: NLM
Share it on

J Clin Virol. 2020 Aug;129:104526. doi: 10.1016/j.jcv.2020.104526. Epub 2020 Jun 29.

Response to letter of concern by Oladimeji and Pickford of PrimerDesign.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Puck B van Kasteren, Bas van der Veer, Chantal B E M Reusken, Adam Meijer

Affiliations

  1. National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control (CIb), Bilthoven, the Netherlands.
  2. National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control (CIb), Bilthoven, the Netherlands. Electronic address: [email protected].

PMID: 32683281 PMCID: PMC7323679 DOI: 10.1016/j.jcv.2020.104526

[No abstract available.]

Conflict of interest statement

Declaration of Competing Interest None.

References

  1. J Clin Virol. 2020 Jul;128:104412 - PubMed

Publication Types